From: Urinary phthalate exposures and risk of breast cancer: the Multiethnic Cohort study
Summary phthalate | All women | |||
---|---|---|---|---|
HR+ n = 694 | HR− n = 96 | |||
OR (95% CI)a | Cases/controls | OR (95% CI)a | Cases/controls | |
∑DEHP | ||||
< 118.53 | 1.00 | 443/508 | 1.00 | 58/508 |
≥ 118.53 | 1.02 (0.82–1.26) | 251/288 | 1.05 (0.67–1.64) | 38/288 |
P value | 0.87 | 0.83 | ||
P hetb | 0.90 | |||
∑HMWP | ||||
< 106.79 | 1.00 | 369/405 | 1.00 | 45/405 |
≥ 106.79 | 0.93 (0.76–1.15) | 325/391 | 1.15 (0.75–1.78) | 51/391 |
P value | 0.50 | 0.52 | ||
P hetb | 0.39 | |||
∑LMWP | ||||
< 93.03 | 1.00 | 317/408 | 1.00 | 40/408 |
≥ 93.03 | 1.30 (1.05–1.60) | 377/388 | 1.28 (0.81–2.00) | 56/388 |
P value | 0.015 | 0.29 | ||
P hetb | 0.95 | |||
∑LMHMPA | ||||
< 310.52 | 1.00 | 332/408 | 1.00 | 38/408 |
≥ 310.52 | 1.17 (0.95–1.44) | 362/388 | 1.54 (0.98–2.41) | 58/388 |
P value | 0.15 | 0.06 | ||
P hetb | 0.28 | |||
∑LMHMmolar | ||||
< 0.80 | 1.00 | 331/411 | 1.00 | 40/411 |
≥ 0.80 | 1.20 (0.98–1.48) | 363/385 | 1.40 (0.90–2.19) | 56/385 |
P value | 0.08 | 0.14 | ||
P hetb | 0.55 | |||
Phthalic acid | ||||
< 53.54 | 1.00 | 343/399 | 1.00 | 36/399 |
≥ 53.54 | 1.02 (0.83–1.26) | 351/397 | 1.59 (1.01–2.48) | 60/397 |
P value | 0.84 | 0.04 | ||
P hetb | 0.08 |